Cellero T cells Validate Red Blood Cell-Facilitated Cancer Immunotherapy
A new study published in Nature Communications cites using Cellero human primary isolated T cells to test a new strategy that uses red blood cells (RBCs) as antigen-presenting cells. [1] The research team who published the study last month hail from the renowned biotech hub in Cambridge, Massachusetts. They came up with their novel strategy…